Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knight, L. C.
Right arrow Articles by Berger, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, L. C.
Right arrow Articles by Berger, H. J.

Radiology, Vol 173, 163-169, Copyright © 1989 by Radiological Society of North America

ARTICLES

Tc-99m antifibrin Fab' fragments for imaging venous thrombi: evaluation in a canine model

LC Knight, AH Maurer, IA Ammar, LA Epps, RT Dean, KY Pak and HJ Berger
Department of Diagnostic Imaging, Temple University School of Medicine and Hospital, Philadelphia, PA 19140.

An antifibrin antibody (T2G1s) Fab' fragment labeled with technetium- 99m was tested for its ability to produce images of fresh thrombi in dogs. In gamma camera images, all thrombi were evident by 2-4 hours after injection. Mean thrombus-to-blood and thrombus-to-muscle ratios averaged 4.0 and 69 at four hours after injection and increased to 24 and 270, respectively, by 24 hours after injection. When compared with I-125 fibrinogen injected into the same dogs, Tc-99m-antifibrin Fab' had lower absolute uptake in thrombus but higher thrombus-to-blood ratios due to a faster rate of disappearance from the blood. The primary route of excretion was through the kidneys. Tc-99m-antifibrin Fab' was highly stable in vivo, with an average of 82% of the circulating radioactivity able to bind to fibrin at 4 hours after injection. When compared with an In-111-labeled Fab fragment of antifibrin antibody 59D8, thrombus-to-blood and thrombus-to-muscle ratios were slightly higher for the Tc-99m-labeled antibody, and the blood disappearance rate was slightly faster. The absolute uptake in thrombus, however, was not significantly different, and the thrombus was visualized at about the same time after injection. These studies suggest that Tc-99m T2G1s Fab' is a potential agent for detecting thrombi in a clinical setting.


This article has been cited by other articles:


Home page
 CirculationHome page
T. A. Morris, J. J. Marsh, R. Konopka, C. A. Pedersen, P. G. Chiles, R. Fagnani, M. Hagan, and K. M. Moser
Antibodies Against the Fibrin ß-Chain Amino-Terminus Detect Active Canine Venous Thrombi
Circulation, November 4, 1997; 96(9): 3173 - 3179.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. R. Stratton, T. A. Dewhurst, S. Kasina, J. M. Reno, M. D. Cerqueira, D. G. Baskin, and J. F. Tait
Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi
Circulation, November 15, 1995; 92(10): 3113 - 3121.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1989 by the Radiological Society of North America.